According to the research report, the global bioprocesstechnology market size is expected to touch USD 79 Billion by 2032, from USD 20.8 Billion in 2022, growing with a significant CAGR of 14.26% from 2023 to 2032.
The bioprocess technology market report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global bioprocess technology market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global bioprocess technology market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global bioprocess technology market during the forecast
period. It also includes a key indicator assessment that highlights growth
prospects of this market and estimates statistics related to growth of the
market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/2501
| Report Coverage | Details |
| Market Size in 2022 | USD 20.8 Billion |
| Market Size by 2032 | USD 79 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 14.26% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Largest Market | North America |
| Segments Covered | By Product Type, By Application, By End-Use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
This study covers a detailed segmentation
of the global bioprocess technology market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global bioprocess technology market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- Philips Healthcare
- Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Becton, Dickinson, and Company
- Sartorius Group
- Abbott Laboratories
- Danaher
- Alere Inc.
Market Segmentation
- Biologics Safety Testing
- Cell Culture
- Cell Expansion
- Cell Line Development
- Flow Cytometry
- Tangential Flow Filtration
- Flow Cytometry
By Application
- Antibiotics
- Biosimilars
- Recombinant Proteins
- Others
By End-Use
- Biopharmaceutical Companies
- Contract Manufacturing Organization
- Academic Research Institutes
- Food and Feed Industry
- Contract Research Organization
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Research Methodology
The research methodology adopted by
analysts for compiling the global bioprocess technology market report is based
on detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global bioprocess technology market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bioprocess Technology Market
5.1. COVID-19 Landscape: Bioprocess Technology Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bioprocess Technology Market, By Product Type
8.1. Bioprocess Technology Market, by Product Type, 2022-2032
8.1.1 Biologics Safety Testing
8.1.1.1. Market Revenue and Forecast (2022-2032)
8.1.2. Cell Culture
8.1.2.1. Market Revenue and Forecast (2022-2032)
8.1.3. Cell Expansion
8.1.3.1. Market Revenue and Forecast (2022-2032)
8.1.4. Cell Line Development
8.1.4.1. Market Revenue and Forecast (2022-2032)
8.1.5. Flow Cytometry
8.1.5.1. Market Revenue and Forecast (2022-2032)
8.1.6. Tangential Flow Filtration
8.1.6.1. Market Revenue and Forecast (2022-2032)
8.1.6. Flow Cytometry
8.1.6.1. Market Revenue and Forecast (2022-2032)
Chapter 9. Global Bioprocess Technology Market, By Application
9.1. Bioprocess Technology Market, by Application, 2022-2032
9.1.1. Antibiotics
9.1.1.1. Market Revenue and Forecast (2022-2032)
9.1.2. Biosimilars
9.1.2.1. Market Revenue and Forecast (2022-2032)
9.1.3. Recombinant Proteins
9.1.3.1. Market Revenue and Forecast (2022-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2022-2032)
Chapter 10. Global Bioprocess Technology Market, By End-Use
10.1. Bioprocess Technology Market, by End-Use, 2022-2032
10.1.1. Biopharmaceutical Companies
10.1.1.1. Market Revenue and Forecast (2022-2032)
10.1.2. Contract Manufacturing Organization
10.1.2.1. Market Revenue and Forecast (2022-2032)
10.1.3. Academic Research Institutes
10.1.3.1. Market Revenue and Forecast (2022-2032)
10.1.4. Food and Feed Industry
10.1.4.1. Market Revenue and Forecast (2022-2032)
10.1.5. Contract Research Organization
10.1.5.1. Market Revenue and Forecast (2022-2032)
Chapter 11. Global Bioprocess Technology Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.1.2. Market Revenue and Forecast, by Application (2022-2032)
11.1.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2022-2032)
11.1.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2022-2032)
11.1.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.2.2. Market Revenue and Forecast, by Application (2022-2032)
11.2.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2022-2032)
11.2.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2022-2032)
11.2.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2022-2032)
11.2.6.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2022-2032)
11.2.7.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.3.2. Market Revenue and Forecast, by Application (2022-2032)
11.3.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2022-2032)
11.3.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2022-2032)
11.3.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2022-2032)
11.3.6.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2022-2032)
11.3.7.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.4.2. Market Revenue and Forecast, by Application (2022-2032)
11.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2022-2032)
11.4.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2022-2032)
11.4.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2022-2032)
11.4.6.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2022-2032)
11.4.7.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.5.2. Market Revenue and Forecast, by Application (2022-2032)
11.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2022-2032)
11.5.4.3. Market Revenue and Forecast, by End-Use (2022-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product Type (2022-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2022-2032)
11.5.5.3. Market Revenue and Forecast, by End-Use (2022-2032)
Chapter 12. Company Profiles
12.1. Philips Healthcare
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Hoffmann-La Roche Ltd.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Thermo Fisher Scientific Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Becton, Dickinson, and Company
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Sartorius Group
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Abbott Laboratories
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Danaher
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Alere Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments